HUP0100737A3 - Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions - Google Patents
Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositionsInfo
- Publication number
- HUP0100737A3 HUP0100737A3 HU0100737A HUP0100737A HUP0100737A3 HU P0100737 A3 HUP0100737 A3 HU P0100737A3 HU 0100737 A HU0100737 A HU 0100737A HU P0100737 A HUP0100737 A HU P0100737A HU P0100737 A3 HUP0100737 A3 HU P0100737A3
- Authority
- HU
- Hungary
- Prior art keywords
- phytosterol
- alzheimer
- delaying
- onset
- disease
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/993,901 US5985936A (en) | 1997-12-18 | 1997-12-18 | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
PCT/CA1998/001147 WO1999032097A2 (en) | 1997-12-18 | 1998-12-18 | Phytosterol composition for preventing alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0100737A2 HUP0100737A2 (hu) | 2001-09-28 |
HUP0100737A3 true HUP0100737A3 (en) | 2002-07-29 |
Family
ID=25540052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0100737A HUP0100737A3 (en) | 1997-12-18 | 1998-12-18 | Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions |
Country Status (18)
Country | Link |
---|---|
US (1) | US5985936A (hu) |
EP (1) | EP0967982A2 (hu) |
CN (1) | CN1252724A (hu) |
AU (1) | AU1656099A (hu) |
BG (1) | BG103740A (hu) |
BR (1) | BR9807577A (hu) |
CA (1) | CA2281710A1 (hu) |
EE (1) | EE9900354A (hu) |
GE (1) | GEP20022783B (hu) |
HU (1) | HUP0100737A3 (hu) |
LT (1) | LT4801B (hu) |
LV (1) | LV12438B (hu) |
MD (1) | MD1920F2 (hu) |
NO (1) | NO993979L (hu) |
PL (1) | PL335421A1 (hu) |
RU (1) | RU2173151C2 (hu) |
SK (1) | SK112999A3 (hu) |
WO (1) | WO1999032097A2 (hu) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8679534B2 (en) * | 1997-12-12 | 2014-03-25 | Andrx Labs, Llc | HMG-CoA reductase inhibitor extended release formulation |
AU780624B2 (en) * | 1999-11-04 | 2005-04-07 | Andrx Corporation | Method of treating amyloid beta precursor disorders |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
AU2001253294A1 (en) | 2000-04-14 | 2001-10-30 | Mars, Incorporated | Compositions and methods for improving vascular health |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
US20040106124A1 (en) * | 2001-02-12 | 2004-06-03 | Murphy Greer M. | Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 and for improving the terapeutic response of humans having major depression and carrying the gene for apolipoprotein e4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
DE10154221A1 (de) * | 2001-11-07 | 2003-05-15 | Max Delbrueck Centrum | Mittel zur Behandlung von Läsionen des Nervensystems |
FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
ES2318274T3 (es) | 2003-03-07 | 2009-05-01 | Schering Corporation | Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia. |
EP1601668B1 (en) | 2003-03-07 | 2008-08-27 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
CA2517573C (en) * | 2003-03-07 | 2011-12-06 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
GB0513881D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
AU2005208566A1 (en) * | 2004-01-22 | 2005-08-11 | Genaissance Pharmaceuticals, Inc. | APOE genetic markers associated with age of onset of Alzheimer's Disease |
WO2006068768A2 (en) * | 2004-11-24 | 2006-06-29 | Hanna Skubatch | Methods and compositions for treating conditions |
GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
GB0513883D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
GB0513888D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
CA2719749A1 (en) * | 2008-03-27 | 2009-10-01 | Evotec Neurosciences Gmbh | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
WO2010104375A1 (en) | 2009-03-12 | 2010-09-16 | N.V. Nutricia | Stigmasterol for the treatment of alzheimer's disease |
US9011937B2 (en) | 2010-11-22 | 2015-04-21 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
US10307450B2 (en) | 2010-01-11 | 2019-06-04 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
US10383886B2 (en) | 2010-01-11 | 2019-08-20 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with oleandrin |
US9376481B2 (en) | 2011-04-26 | 2016-06-28 | The Regents Of The University Of California | Methods of promoting CNS neuronal repair by inhibiting LRP-1 |
CN102813659A (zh) * | 2012-08-21 | 2012-12-12 | 贵阳中医学院 | 20α-二甲胺基- 2α-羟基-3β-惕洛酰胺基-5α-孕甾烷的用途 |
WO2015123617A1 (en) * | 2014-02-14 | 2015-08-20 | Arizona Board Of Regents For The University Of Arizona | Method for reducing bcl2 gene expression |
US10702567B2 (en) | 2016-09-14 | 2020-07-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
US10596186B2 (en) | 2016-09-14 | 2020-03-24 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infections |
RU2758376C2 (ru) | 2017-09-14 | 2021-10-28 | Феникс Байотекнолоджи, Инк. | Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний |
US11331291B2 (en) | 2017-09-14 | 2022-05-17 | Phoenix Biotechnology, Inc. | Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders |
US20230263809A1 (en) | 2019-12-24 | 2023-08-24 | Folium Biosciences Europe B.V. | Food supplement for alzheimer |
EP3842039A1 (en) * | 2019-12-24 | 2021-06-30 | Folium Biosciences Europe B.V. | Food supplement comprising cannbinoids and phytosterols for alzheimer |
US11806359B2 (en) | 2020-03-31 | 2023-11-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating Coronavirus infection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
AU6274394A (en) * | 1993-02-23 | 1994-09-14 | Pharmakon Usa, Inc. | Therapeutic herbal composition |
US5589182A (en) * | 1993-12-06 | 1996-12-31 | Tashiro; Renki | Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression |
BR9509119A (pt) * | 1994-09-29 | 1997-10-28 | Univ British Columbia | Processo para o isolamento de uma composição de fitoesteróis a partir de um sabão de polpa composição diminuidora de colesterol e produto terapeuticamente eficaz para prevenir ou tratar aterosclerose ou dislipidemias primárias ou secundárias |
CN1179903A (zh) * | 1996-10-09 | 1998-04-29 | 李辉 | 营养丝米粉 |
ATE359071T1 (de) * | 1997-05-15 | 2007-05-15 | Univ Washington | Zusammensetzung und verfahren zur behandlung der alzheimer'schen krankheit und anderen amyloidosen |
-
1997
- 1997-12-18 US US08/993,901 patent/US5985936A/en not_active Expired - Fee Related
-
1998
- 1998-12-18 HU HU0100737A patent/HUP0100737A3/hu unknown
- 1998-12-18 GE GEAP19984990A patent/GEP20022783B/en unknown
- 1998-12-18 PL PL98335421A patent/PL335421A1/xx unknown
- 1998-12-18 EP EP98960959A patent/EP0967982A2/en not_active Ceased
- 1998-12-18 SK SK1129-99A patent/SK112999A3/sk unknown
- 1998-12-18 AU AU16560/99A patent/AU1656099A/en not_active Abandoned
- 1998-12-18 EE EEP199900354A patent/EE9900354A/xx unknown
- 1998-12-18 CN CN98804259A patent/CN1252724A/zh active Pending
- 1998-12-18 BR BR9807577-2A patent/BR9807577A/pt not_active IP Right Cessation
- 1998-12-18 WO PCT/CA1998/001147 patent/WO1999032097A2/en not_active Application Discontinuation
- 1998-12-18 MD MD99-0262A patent/MD1920F2/ro unknown
- 1998-12-18 RU RU99120072/14A patent/RU2173151C2/ru not_active IP Right Cessation
- 1998-12-18 CA CA002281710A patent/CA2281710A1/en not_active Abandoned
-
1999
- 1999-08-18 NO NO993979A patent/NO993979L/no not_active Application Discontinuation
- 1999-09-16 LT LT1999114A patent/LT4801B/lt not_active IP Right Cessation
- 1999-09-17 BG BG103740A patent/BG103740A/xx unknown
- 1999-09-17 LV LVP-99-134A patent/LV12438B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK112999A3 (en) | 2001-11-06 |
AU1656099A (en) | 1999-07-12 |
WO1999032097A3 (en) | 1999-09-02 |
US5985936A (en) | 1999-11-16 |
EE9900354A (et) | 2000-02-15 |
LT4801B (lt) | 2001-06-25 |
PL335421A1 (en) | 2000-04-25 |
BR9807577A (pt) | 2001-08-07 |
NO993979D0 (no) | 1999-08-18 |
EP0967982A2 (en) | 2000-01-05 |
NO993979L (no) | 1999-10-13 |
GEP20022783B (en) | 2002-09-25 |
LV12438B (en) | 2000-09-20 |
BG103740A (en) | 2000-05-31 |
LT99114A (lt) | 2001-01-25 |
RU2173151C2 (ru) | 2001-09-10 |
WO1999032097A2 (en) | 1999-07-01 |
CA2281710A1 (en) | 1999-07-01 |
CN1252724A (zh) | 2000-05-10 |
MD1920F2 (ro) | 2002-05-31 |
HUP0100737A2 (hu) | 2001-09-28 |
MD990262A (en) | 2000-06-30 |
LV12438A (en) | 2000-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100737A3 (en) | Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions | |
HUS1200028I1 (hu) | 4"-Szubsztituált-9-dezoxo-9a-aza-9a-homoeritromicin-származékok és ezeket tartalmazó gyógyszerek | |
HUP0103654A2 (hu) | Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására | |
HUP0001442A3 (en) | Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders | |
IL135800A0 (en) | Methods and pharmaceutical compositions for the closure of retinal breaks | |
HUP9700709A3 (en) | 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds | |
HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
IL118369A0 (en) | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0001541A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
IL123648A0 (en) | 1,4-Benzothiazepine-1,1-dioxides their preparation and pharmaceutical compositions containing them | |
IL115484A (en) | Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
HUP9902454A3 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
AP2001002102A0 (en) | Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas | |
HUP9800147A3 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
IL124661A0 (en) | 5'-Deoxy-cytidine derivatives their preparation and pharmaceutical compositions containing them | |
HUP0000960A3 (en) | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same | |
HUP0001858A3 (en) | Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds | |
IL135723A (en) | 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them | |
HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
HUP9602196A3 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
HUP0004331A3 (en) | Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it | |
HUP0102025A3 (en) | Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use | |
IL116101A0 (en) | Benzamide its preparation and pharmaceutical compositions containing it | |
IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof |